HCA Healthcare (HCA)
(Real Time Quote from BATS)
$397.23 USD
-6.20 (-1.54%)
Updated Sep 17, 2024 03:42 PM ET
After-Market: $397.50 +0.27 (0.07%) 4:06 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$397.23 USD
-6.20 (-1.54%)
Updated Sep 17, 2024 03:42 PM ET
After-Market: $397.50 +0.27 (0.07%) 4:06 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
Zacks News
Is a Surprise Coming for HCA Healthcare (HCA) This Earnings Season?
by Zacks Equity Research
HCA Healthcare (HCA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
5 Growth Stocks to Buy That Are Poised to Beat on Earnings
by Nalak Das
We have narrowed our search to five growth stocks that are poised to beat on earnings results next week. These are: PH, CMG, ETN, HCA, LII.
HCA Healthcare (HCA) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
The latest trading day saw HCA Healthcare (HCA) settling at $283.43, representing a -0.91% change from its previous close.
Why HCA Healthcare (HCA) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HCA (HCA) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for HCA (HCA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Can Higher Costs Affect HCA Healthcare's (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter results are likely to reflect increased admissions and a lower average length of stay.
Is HCA Healthcare (HCA) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Brokers Suggest Investing in HCA (HCA): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in HCA (HCA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
HCA Healthcare (HCA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
The latest trading day saw HCA Healthcare (HCA) settling at $287.77, representing a +1.04% change from its previous close.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HCA Healthcare, Inc. (HCA) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching HCA (HCA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Here's Why HCA Healthcare (HCA) Fell More Than Broader Market
by Zacks Equity Research
HCA Healthcare (HCA) concluded the recent trading session at $279.33, signifying a -0.77% move from its prior day's close.
HCA Healthcare (HCA) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $275.32, marking a +1.71% move from the previous day.
Reasons to Retain HCA Healthcare (HCA) Stock in Your Portfolio
by Zacks Equity Research
HCA Healthcare's (HCA) improving top line, acquisition initiatives and a robust growth outlook poise the company well for growth.
HCA Healthcare (HCA) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the most recent trading session, HCA Healthcare (HCA) closed at $269.18, indicating a +0.75% shift from the previous trading day.
HCA Healthcare, Inc. (HCA) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Wall Street Bulls Look Optimistic About HCA (HCA): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for HCA (HCA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems are part of the Zacks Industry Outlook article.
5 Hospital Stocks to Watch Amid Promising Industry Trends
by Kaibalya Pravo Dey
Rising patient volumes and technological advancements for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving operating efficiency.
HCA Healthcare (HCA) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $262.02, moving +1.74% from the previous trading session.
HCA Healthcare's (HCA) Houston Affiliate Acquires 11 EDs
by Zacks Equity Research
The deal helps HCA Healthcare (HCA) boost its freestanding EDs in the Houston region to 26, supplementing its existing hospital-based emergency rooms.
HCA Healthcare (HCA) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
HCA Healthcare (HCA) concluded the recent trading session at $257.14, signifying a +1.89% move from its prior day's close.
Investors Heavily Search HCA Healthcare, Inc. (HCA): Here is What You Need to Know
by Zacks Equity Research
HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Wall Street Analysts Think HCA (HCA) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for HCA (HCA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?